Gore launches CQI study for Gore Dualmesh Biomaterial

WL Gore and Associates (Gore) is carrying out a clinical quality improvement (CQI) study for its Gore Dualmesh Biomaterial.

The trial will focus on ways to improve patient and physician experiences in enhancing outcomes when using the material in laparoscopic repair procedures for ventral hernia patients.

Gore will work with Surgical Momentum to implement the study, the initial phase of which will last for one year, with the teams now working to define the clinical processes, size of the patient population and outcomes to be measured.

The manufacturer introduced its Gore Dualmesh Biomaterial in 1993, since which time it has become a proven tool for use in the repair and reconstruction of ventral hernias, with more than 150 peer-reviewed scientific articles published since 1996.

Ron Anderson, business leader for Gore's general medical products business, said: "The launch of a clinical quality improvement study for Gore Dualmesh Biomaterial is an example of Gore's commitment to enhancing the quality of patient care, which is at the core of everything we do."

Earlier this year, Gore was named as the seventh best company in the UK to work for in a report from the Sunday Times, while topping the rankings for Scotland.